Brackenridge, A L, Jackson, N, Jefferson, W, Stolinski, M, Shojaee-Moradie, F, Hovorka, R, Umpleby, A M and Russell-Jones, D (2009) Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids. Diabetic Medicine, 26(5), pp. 532-539. ISSN (print) 0742-3071Full text not available from this archive.
In patients with Type 2 diabetes and normal lipids, treatment with rosiglitazone or pioglitazone had no significant effect on lipoprotein metabolism compared with placebo.
|Research Area:||Allied health professions and studies
Other laboratory based clinical subjects
|Faculty, School or Research Centre:||Faculty of Science, Engineering and Computing
Faculty of Science, Engineering and Computing > School of Life Sciences
|Depositing User:||Michael Stolinski|
|Date Deposited:||26 Jul 2012 11:01|
|Last Modified:||17 Dec 2012 12:08|
Actions (Repository Editors)
|Item Control Page|